Depomed (DEPO) to Acquire U.S. Rights to Cosyntropin, Divest Lazanda in Pact with Slan
Tweet Send to a Friend
Depomed Inc. (NASDAQ: DEPO) announced today that it has entered into an agreement with Slán Medicinal Holdings Limited (“Slán”) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
